147 related articles for article (PubMed ID: 27505301)
1. Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection.
Park SM; Kim JS; Kim BW; Ji JS; Choi H
J Gastroenterol Hepatol; 2017 Mar; 32(3):589-594. PubMed ID: 27505301
[TBL] [Abstract][Full Text] [Related]
2. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
3. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
Auesomwang C; Maneerattanaporn M; Chey WD; Kiratisin P; Leelakusolwong S; Tanwandee T
J Gastroenterol Hepatol; 2018 Nov; 33(11):1822-1828. PubMed ID: 29804294
[TBL] [Abstract][Full Text] [Related]
4. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
[TBL] [Abstract][Full Text] [Related]
5. Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection.
Ang TL; Fock KM; Song M; Ang D; Kwek AB; Ong J; Tan J; Teo EK; Dhamodaran S
J Gastroenterol Hepatol; 2015 Jul; 30(7):1134-9. PubMed ID: 25639278
[TBL] [Abstract][Full Text] [Related]
6. Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.
Heo J; Jeon SW; Jung JT; Kwon JG; Lee DW; Kim HS; Yang CH; Park JB; Park KS; Cho KB; Lee SH; Jang BI;
J Gastroenterol Hepatol; 2015 Sep; 30(9):1361-6. PubMed ID: 25867608
[TBL] [Abstract][Full Text] [Related]
7. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
8. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
9. Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for
Kim BJ; Lee H; Lee YC; Jeon SW; Kim GH; Kim HS; Sung JK; Lee DH; Kim HU; Park MI; Choi IJ; Yoon SM; Kim SW; Baik GH; Lee JY; Kim JI; Kim SG; Kim J; Lee J; Kim JG; Kim JJ;
Gut Liver; 2019 Sep; 13(5):531-540. PubMed ID: 31505907
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC
Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication.
Huang YK; Wu MC; Wang SS; Kuo CH; Lee YC; Chang LL; Wang TH; Chen YH; Wang WM; Wu DC; Kuo FC
J Dig Dis; 2012 Apr; 13(4):232-8. PubMed ID: 22435509
[TBL] [Abstract][Full Text] [Related]
12. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.
Oh HS; Lee DH; Seo JY; Cho YR; Kim N; Jeoung SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Cho HJ; Jung HC; Song IS
J Gastroenterol Hepatol; 2012 Mar; 27(3):504-9. PubMed ID: 21916989
[TBL] [Abstract][Full Text] [Related]
13. Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.
Sardarian H; Fakheri H; Hosseini V; Taghvaei T; Maleki I; Mokhtare M
Helicobacter; 2013 Apr; 18(2):129-34. PubMed ID: 23121338
[TBL] [Abstract][Full Text] [Related]
14. Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection.
Hsu PI; Tsay FW; Kao JY; Peng NJ; Tsai KW; Tsai TJ; Kuo CH; Kao SS; Wang HM; Chen YH; Shie CB; Wu DC;
J Gastroenterol Hepatol; 2020 Oct; 35(10):1731-1737. PubMed ID: 32167605
[TBL] [Abstract][Full Text] [Related]
15. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.
Greenberg ER; Anderson GL; Morgan DR; Torres J; Chey WD; Bravo LE; Dominguez RL; Ferreccio C; Herrero R; Lazcano-Ponce EC; Meza-Montenegro MM; Peña R; Peña EM; Salazar-Martínez E; Correa P; Martínez ME; Valdivieso M; Goodman GE; Crowley JJ; Baker LH
Lancet; 2011 Aug; 378(9790):507-14. PubMed ID: 21777974
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
Georgopoulos SD; Xirouchakis E; Martinez-Gonzales B; Zampeli E; Grivas E; Spiliadi C; Sotiropoulou M; Petraki K; Zografos K; Laoudi F; Sgouras D; Mentis A; Kasapidis P; Michopoulos S
Eur J Intern Med; 2016 Jul; 32():84-90. PubMed ID: 27134145
[TBL] [Abstract][Full Text] [Related]
17. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
Tepeš B; Vujasinović M; Šeruga M; Stefanovič M; Forte A; Jeverica S
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):676-83. PubMed ID: 26862930
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
Lee JY; Kim N; Park KS; Kim HJ; Park SM; Baik GH; Shim KN; Oh JH; Choi SC; Kim SE; Kim WH; Park SY; Kim GH; Lee BE; Jo Y; Hong SJ
BMC Gastroenterol; 2016 Jul; 16(1):79. PubMed ID: 27460100
[TBL] [Abstract][Full Text] [Related]
20. Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study.
Apostolopoulos P; Koumoutsos I; Ekmektzoglou K; Dogantzis P; Vlachou E; Kalantzis C; Tsibouris P; Alexandrakis G
Scand J Gastroenterol; 2016; 51(2):145-51. PubMed ID: 26435055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]